Home
Medison

Medison Market Share Analysis for August 2026

Medison is a global pharma company focused on providing access to highly innovative therapies in international markets

Health > Biotechnology and Pharmaceuticals

Domainmedison.co.il

Year Founded1996

Employees201 - 500

Annual Revenue$25M - $50M

Medison

Medison (including company regionals)

medison.co.il

See more website traffic and engagement information

Medison Revenue up to August 2026 is 25M - 50M

revenue generated by Medison top domains

Medison top domains revenue over 3 years

Revenue for Medison top domains

medison.co.il25M - 50M

See more with Sales Intelligence

Total visits to Medison's top domains

Understand Medison market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

medison.co.il--

See more with Sales Intelligence

Avg. visit duration in Medison's top domains

Analyze Medison engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

medison.co.il--

See more with Sales Intelligence

Avg. pageviews on Medison's top domains

See how Medison keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

medison.co.il--

See more with Sales Intelligence

Medison top competitors by domain

Top similar sites in August 2026, ranked by their affinity

elan.comCompany NameElan CorporationEmployees201 - 500HQIreland, DublinAnnual revenue$100M - $200MTotal visits268Health > Biotechnology and Pharmaceuticals

Top technologies used by Medison

These are the website technologies, by industry, used by Medison top domains

Email Services (4)

Microsoft Exchange Online

Widget (4)

Twemoji

Advertising (2)

PubMatic

Mobile (2)

Meta Viewport

More Technologies

4

See all

News & Signals from Medison

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMedison partnered with Deciphera Pharmaceuticals, Inc. on Nov 6th '20.Medison Pharma, a leading international commercial partner for highly innovative therapies, today announced an exclusive distribution agreement with Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) to commercialize QINLOCK, a switch-control tyrosine kinase inhibitor, in Canada and Israel for the treatment of fourth-line gastrointestinal stromal tumor (GIST).